Abstract
Objective: To review data on efficacy and safety of osilodrostat (Isturisa), a novel oral steroidogenesis inhibitor for treatment of Cushing's disease......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
